Locally Advanced Solid Tumor

Showing 1 - 25 of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ful Mutations in Solid Tumor Characterized by Next Generation

Recruiting
  • Solid Tumor
  • +13 more
    • Aviano, Pordonone, Italy
      IRCCS, Centro di Riferimento Oncologico (CRO) di Aviano
    Sep 8, 2023

    Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

    Recruiting
    • Cancer
    • +11 more
    • San Antonio, Texas
      South Texas Accelerated Research Therapeutics, LLC
    Jun 21, 2023

    NSCLC, Pancreatic Cancer, Locally Advanced Solid Tumor Trial in Sydney (HMBD-001, Docetaxel, Nab-paclitaxel)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Sydney, New South Wales, Australia
      GenesisCare North Shore
    Jun 16, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Canton (repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • repotrectinib (TPX-0005)
    • Canton, Ohio
      Gabrail Cancer Research Center
    Apr 25, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Providence (TY-2136b)

    Not yet recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Providence, Rhode Island
      Rhode Island Hospital, Brown University
    Mar 2, 2023

    Locally Advanced Solid Tumor Trial (TNG462)

    Not yet recruiting
    • Locally Advanced Solid Tumor
    • (no location specified)
    Feb 17, 2023

    Locally Advanced Solid Tumor, Metastatic Tumor Trial in San Antonio (TST003)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Tumor
    • San Antonio, Texas
      NEXT Oncology
    Feb 15, 2023

    Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

    Not yet recruiting
    • Solid Tumor
    • +2 more
    • (no location specified)
    Jan 28, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (NVL-655)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Orange, California
    • +13 more
    Jan 31, 2023

    Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

    Recruiting
    • Cancer
    • +4 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Jan 24, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in China (VC004)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Hefei, Anhui, China
    • +20 more
    Dec 11, 2022

    Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,

    Recruiting
    • Advanced Solid Tumor
    • +7 more
    • TransCon IL-2 β/γ
    • +4 more
    • Boston, Massachusetts
    • +7 more
    Nov 16, 2022

    Locally Advanced Solid Tumor Trial in United States (TNG908)

    Recruiting
    • Locally Advanced Solid Tumor
    • Boston, Massachusetts
    • +7 more
    Nov 13, 2022

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Worldwide (NVL-520)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Orange, California
    • +18 more
    Oct 6, 2022

    Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

    Recruiting
    • Advanced Solid Tumor
    • +6 more
    • Duarte, California
    • +12 more
    Sep 21, 2022

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Denver, Colorado
    • +3 more
    Aug 19, 2022

    A Retro-/Prospective, Non-interventional, Cohort Study in Adult

    Active, not recruiting
    • Solid Tumor, Adult
    • +2 more
      • Amiens, France
      • +3 more
      Jul 22, 2022

      Locally Advanced Solid Tumor Trial in United States (OBI-999)

      Recruiting
      • Locally Advanced Solid Tumor
      • La Jolla, California
      • +3 more
      Jul 5, 2022

      HER2-positive, Locally Advanced Solid Tumor, Immunotherapy Trial in Beijing (sintilimab, Trastuzumab, S-1 plus oxaliplatin)

      Not yet recruiting
      • HER2-positive
      • +6 more
      • Beijing, China
        Cancer Hospital & Institute, Chinese Academy of Medical Sciences
      Mar 28, 2022

      Unresectable Solid Tumor, Metastatic Solid Tumor, Locally Advanced Solid Tumor Trial in Australia (RC118 for injection)

      Recruiting
      • Unresectable Solid Tumor
      • +2 more
      • RC118 for injection
      • Macquarie Park, New South Wales, Australia
      • +3 more
      Feb 18, 2022

      Locally Advanced Solid Tumor Trial in United States (AN2025, AN0025, Atezolizumab 1200 mg in 20 ML Injection)

      Recruiting
      • Locally Advanced Solid Tumor
      • Aurora, Colorado
      • +3 more
      Feb 16, 2022

      Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

      Recruiting
      • Urothelial Carcinoma
      • +20 more
      • Gilbert, Arizona
      • +9 more
      Feb 3, 2022

      Locally Advanced Solid Tumor, Metastatic Cancer Trial in United States (CTX-471)

      Recruiting
      • Locally Advanced Solid Tumor
      • Metastatic Cancer
      • Ocala, Florida
      • +9 more
      Sep 29, 2021

      Metastasis, Locally Advanced Solid Tumor, Recurrent Cancer Trial in Stanford, New York (XRD-0394, Palliative radiotherapy)

      Recruiting
      • Metastasis
      • +2 more
      • Stanford, California
      • +1 more
      Sep 27, 2021

      Locally Advanced Solid Tumor, Metastatic Solid Tumor, Hematologic Malignancies Trial (CN202)

      Not yet recruiting
      • Locally Advanced Solid Tumor
      • +2 more
      • (no location specified)
      Aug 25, 2021